title: The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients.
authors.affiliation: Birkmayer Institute for Parkinsontherapy, Vienna, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Birkmayer
authors.forename: J G
authors.initials: JG
authors.lastname: Birkmayer
authors.forename: K
authors.initials: K
authors.lastname: Vrecko
authors.forename: B
authors.initials: B
authors.lastname: Paletta
mesh_terms: D000368:Aged; D004185:Disability Evaluation; D006801:Humans; D007262:Infusions, Intravenous; D007980:Levodopa / Q000378:metabolism*; D008875:Middle Aged; D009243:NAD / Q000008:administration & dosage*; D009460:Neurologic Examination; D010300:Parkinson Disease / Q000628:therapy*
chemical_list: D009243:NAD; D007980:Levodopa